News
Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...
The FDA is still on track to meet its user fee targets despite a higher-than-normal vacancy rate among scientific reviewers.
The recall has been given a Class II classification, indicating there is a significant level of risk posed to consumers in ...
Commissioner Marty Makary said in an interview with Politico’s Dasha Burns that the FDA will “look at the data” surrounding ...
People with an allergy or severe sensitivity to peanuts "may risk serious or life-threatening allergic reactions by consuming ...
The U.S. Food and Drug Administration has extended its review of Bayer's experimental menopause relief drug, the German ...
Food and Drug Administration Commissioner Marty Makary said he has “no preconceived plans” to change the policies on ...
Commissioner Marty Makary says the FDA will plow ahead with big plans on ultra process foods, dietary guidelines and ...
The U.S. drug regulator said on Friday a unit of Johnson & Johnson issued a correction for certain lots of a part related to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results